Le Lézard
Classified in: Health, Science and technology

In-Depth Analysis of the Emerging Targeted Protein Degradation (TPD) Space, 2023 Research Report - Opportunities in Research and Product Development Partnerships to Develop Next-gen TPD Therapeutics - ResearchAndMarkets.com

The "Emerging Landscape of Targeted Protein Degradation Therapeutics" report has been added to ResearchAndMarkets.com's offering.

This insightful research report delves into the burgeoning field of targeted protein degradation (TPD), a promising approach for treating previously untreatable diseases by precisely targeting disease-causing proteins, minimizing potential side effects.

It provides an extensive analysis of various TPD strategies, including extracellular and intracellular protein degraders, their applicability across diseases, key players in clinical translation, and identifies four transformative growth opportunities in the TPD market.

With approximately 80% of a cell's proteome resistant to conventional treatments, TPD has emerged as a crucial advancement, with PROTACs as a prominent protein degrader.

This report explores the development of intracellular and extracellular degraders, addressing the limitations of each. Furthermore, it highlights the role of increased private and public funding in propelling the growth of TPD technology, offering valuable insights into funding trends within the TPD space.

Questions that this report seeks to answer include:

Key Topics Covered:

1 Strategic Imperatives

2 Growth Opportunity Analysis

3 R&D and Innovation Ecosystem

4 R&D Focus and Application Landscape

5 Market Dynamics

6 Growth Opportunity Universe

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/1gfv78

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

These press releases may also interest you

at 04:15
The global biochips market size is estimated to grow by USD 43.27 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 25.15% during the forecast period. North America is estimated to account for 41% of the...

at 04:06
ITAAN Pharma and ACIC Pharmaceuticals join forces in a strategic venture to advance generic injectables for the North American market. The collaboration is for enhanced product development and manufacturing excellence, resulting in a comprehensive...

at 04:05
UE Systems, a pioneering force in developing ultrasonic detection instruments and solutions for maintenance and reliability, unveils its latest innovation ? the OnTrak Wireless system. This cutting-edge solution transcends traditional bearing health...

at 04:00
Pioneering UK-based bio-tech...

at 03:59
In Q2 2023, Amador Bioscience, a next generation CRO focusing on translational science and early clinical development, announced the addition of Dr. Lorin Roskos to the Board of Directors. Dr. Roskos has also taken on the roles of Chief Scientific...

at 03:50
--The Phase III clinical trial of ASC40 for moderate to severe acne vulgaris will enroll 480 subjects --The protocol of Phase III clinical trial has been agreed by Center for Drug Evaluation, National Medical Products Administration and obtained the...

News published on and distributed by: